1. Huang, Zhuqi, Shen, Sirui, Wang, Mengyang, Luo, Wu, Liang, Guang. 2022. Mouse endothelial OTUD1 promotes angiotensin II-induced vascular remodeling by deubiquitinating SMAD3. In EMBO reports, 24, e56135. doi:10.15252/embr.202256135. https://pubmed.ncbi.nlm.nih.gov/36579465/
2. Lu, Dan, Song, Jia, Sun, Yizhe, McNutt, Michael A, Yin, Yuxin. 2018. Mutations of deubiquitinase OTUD1 are associated with autoimmune disorders. In Journal of autoimmunity, 94, 156-165. doi:10.1016/j.jaut.2018.07.019. https://pubmed.ncbi.nlm.nih.gov/30100102/
3. Zhou, Tao, Wu, Yihao, Qian, Da, Meng, Xuli, Zheng, Qinghui. 2023. OTUD1 chemosensitizes triple-negative breast cancer to doxorubicin by modulating P16 expression. In Pathology, research and practice, 247, 154571. doi:10.1016/j.prp.2023.154571. https://pubmed.ncbi.nlm.nih.gov/37257246/
4. Zhang, Qi, Li, Jinglei, Chen, Zihan, Zhang, Jinxiang, Wang, Hui. 2023. VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma. In Cellular oncology (Dordrecht, Netherlands), 46, 1001-1014. doi:10.1007/s13402-023-00793-x. https://pubmed.ncbi.nlm.nih.gov/36929488/
5. Zhu, Weiwei, Zhang, Qianhui, Jin, Leiming, Luo, Wu, Zhuang, Zaishou. 2024. OTUD1 Deficiency Alleviates LPS-Induced Acute Lung Injury in Mice by Reducing Inflammatory Response. In Inflammation, , . doi:10.1007/s10753-024-02074-7. https://pubmed.ncbi.nlm.nih.gov/39037666/
智鼠故事 
